A share price of Bio-Techne Corp [TECH] is currently trading at $61.86, up 0.42%. An important factor to consider is whether the stock is rising or falling in short-term value. The TECH shares have gain 5.46% over the last week, with a monthly amount glided 16.74%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bio-Techne Corp [NASDAQ: TECH] stock has seen the most recent analyst activity on September 03, 2025, when RBC Capital Mkts upgraded its rating to a Outperform but kept the price target unchanged to $73 for it. Previously, Citigroup upgraded its rating to Buy on August 21, 2025, and kept the price target unchanged to $70. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $65 on July 09, 2025. Wells Fargo initiated its recommendation with a Overweight and recommended $59 as its price target on May 30, 2025. KeyBanc Capital Markets downgraded its rating to Sector Weight for this stock on April 09, 2025. In a note dated March 18, 2025, Evercore ISI initiated an Outperform rating and provided a target price of $75 on this stock.
Bio-Techne Corp experienced fluctuations in its stock price throughout the past year between $46.01 and $80.80. Currently, Wall Street analysts expect the stock to reach $73 within the next 12 months. Bio-Techne Corp [NASDAQ: TECH] shares were valued at $61.86 at the most recent close of the market. An investor can expect a potential return of 18.01% based on the average TECH price forecast.
Analyzing the TECH fundamentals
Trailing Twelve Months sales for Bio-Techne Corp [NASDAQ:TECH] were 1.22B which represents 3.55% growth. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.04 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 61.21 points at the first support level, and at 60.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 62.47, and for the 2nd resistance point, it is at 63.08.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Bio-Techne Corp [NASDAQ:TECH] is 3.46. On the other hand, the Quick Ratio is 2.38, and the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 7.90, the price to book ratio is 5.00 and price to earnings (TTM) ratio is 136.41.
Transactions by insiders
Recent insider trading involved Nusse Roeland, Director, that happened on Aug 25 ’25 when 17040.0 shares were sold. Director, BAUMGARTNER ROBERT V completed a deal on Aug 25 ’25 to sell 17040.0 shares. Meanwhile, Director ROELAND NUSSE bought 17040.0 shares on Aug 25 ’25.
